<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37328666</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-0100</ISSN><JournalIssue CitedMedium="Internet"><Volume>81</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Endocrine</Title><ISOAbbreviation>Endocrine</ISOAbbreviation></Journal><ArticleTitle>Potential impacts of SARS-CoV-2 on parathyroid: current advances and trends.</ArticleTitle><Pagination><StartPage>391</StartPage><EndPage>408</EndPage><MedlinePgn>391-408</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12020-023-03415-6</ELocationID><Abstract><AbstractText>Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection affects several important organs including endocrine glands. Experimental studies demonstrated that the virus exploits the ACE2, a transmembrane glycoprotein on the cell surface as a receptor for cellular entry. This entry process is exclusively facilitated by other intracellular protein molecules such as TMPRSS2, furin, NRP1, and NRP2. Recent findings documented the involvement of the SARS-CoV-2 in inducing various parathyroid disorders including hypoparathyroidism and hypocalcemia, which received significant attention. This review extensively describes rapidly evolving knowledge on the potential part of SARS-CoV-2 in emerging various parathyroid disorders due to SARS-CoV-2 infection particularly parathyroid malfunction in COVID-19 cases, and post-COVID-19 conditions. Further, it presents the expression level of various molecules such as ACE2, TMPRSS2, furin, NRP1, and NRP2 in the parathyroid cells that facilitate the SARS-CoV-2 entry into the cell, and discusses the possible mechanism of parathyroid gland infection. Besides, it explores parathyroid malfunction in COVID-19 vaccine-administered cases. It also explains the possible long-COVID-19 effect on parathyroid and post-COVID-19 management of parathyroid. A complete understanding of the mechanisms of SARS-CoV-2-triggered pathogenesis in parathyroid dysfunctions may curtail treatment options and aid in the management of SARS-CoV-2-infected cases.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Murugan</LastName><ForeName>Avaniyapuram Kannan</ForeName><Initials>AK</Initials><Identifier Source="ORCID">0000-0002-3096-6100</Identifier><AffiliationInfo><Affiliation>Division of Molecular Endocrinology, Department of Molecular Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh, 11211, Saudi Arabia. akmurugan@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alzahrani</LastName><ForeName>Ali S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Division of Molecular Endocrinology, Department of Molecular Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh, 11211, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, 11211, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Endocrine</MedlineTA><NlmUniqueID>9434444</NlmUniqueID><ISSNLinking>1355-008X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.21.75</RegistryNumber><NameOfSubstance UI="D045683">Furin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.15.1</RegistryNumber><NameOfSubstance UI="D007703">Peptidyl-Dipeptidase A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045683" MajorTopicYN="N">Furin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010280" MajorTopicYN="N">Parathyroid Glands</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="N">Angiotensin-Converting Enzyme 2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007703" MajorTopicYN="N">Peptidyl-Dipeptidase A</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Hyperparathyroidism</Keyword><Keyword MajorTopicYN="N">Hypoparathyroidism</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Parathyroid</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>17</Day><Hour>5</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>16</Day><Hour>23</Hour><Minute>29</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37328666</ArticleId><ArticleId IdType="doi">10.1007/s12020-023-03415-6</ArticleId><ArticleId IdType="pii">10.1007/s12020-023-03415-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>E. Fan, J.R. Beitler, L. Brochard, C.S. Calfee, N.D. Ferguson, A.S. Slutsky et al. COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted. ? Lancet Respir Med 8(8), 816&#x2013;821 (2020). https://doi.org/10.1016/S2213-2600(20)30304-0</Citation></Reference><Reference><Citation>COVID-19 data portal, The World Health Organizations. https://covid19.who.int/ . Last accessed on May 17, 2023</Citation></Reference><Reference><Citation>Y. Asai, H. Nomoto, K. Hayakawa, N. Matsunaga, S. Tsuzuki, M. Terada et al. Comorbidities as Risk Factors for Severe Disease in Hospitalized Elderly COVID-19 Patients by Different Age-Groups in Japan. Gerontology 68(9), 1027&#x2013;1037 (2022). https://doi.org/10.1159/000521000</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000521000</ArticleId><ArticleId IdType="pubmed">34999588</ArticleId></ArticleIdList></Reference><Reference><Citation>M.Y. Li, L. Li, Y. Zhang, X.S. Wang, Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect. Dis. Poverty 9, 45 (2020). https://doi.org/10.1186/s40249-020-00662-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-020-00662-x</ArticleId><ArticleId IdType="pubmed">32345362</ArticleId><ArticleId IdType="pmc">7186534</ArticleId></ArticleIdList></Reference><Reference><Citation>G. Lisco, A. De Tullio, A. Stragapede, A.G. Solimando, F. Albanese, M. Capobianco et al. COVID-19 and the Endocrine System: A Comprehensive Review on the Theme. J. Clin. Med 10(13), 2920 (2021). https://doi.org/10.3390/jcm10132920</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10132920</ArticleId><ArticleId IdType="pubmed">34209964</ArticleId><ArticleId IdType="pmc">8269331</ArticleId></ArticleIdList></Reference><Reference><Citation>G. Lisco, A. De Tullio, E. Jirillo, V.A. Giagulli, G. De Pergola, E. Guastamacchia et al. Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects. J. Endocrinol. Investig. 44(9), 1801&#x2013;1814 (2021). https://doi.org/10.1007/s40618-021-01554-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-021-01554-z</ArticleId></ArticleIdList></Reference><Reference><Citation>G. Lisco, V.A. Giagulli, G. De Pergola, A. De Tullio, E. Guastamacchia, V. Triggiani, Covid-19 in Man: A Very Dangerous Affair. Endocr. Metab. Immune Disord. Drug Targets 21(9), 1544&#x2013;1554 (2021). https://doi.org/10.2174/1871530321666210101123801</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871530321666210101123801</ArticleId><ArticleId IdType="pubmed">33388025</ArticleId></ArticleIdList></Reference><Reference><Citation>V.A. Giagulli, E. Guastamacchia, T. Magrone, E. Jirillo, G. Lisco, G. De Pergola et al. Worse progression of COVID-19 in men: Is testosterone a key factor? Andrology 9(1), 53&#x2013;64 (2021). https://doi.org/10.1111/andr.12836</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/andr.12836</ArticleId><ArticleId IdType="pubmed">32524732</ArticleId></ArticleIdList></Reference><Reference><Citation>T. Fiolet, Y. Kherabi, C.J. MacDonald, J. Ghosn, N. Peiffer-Smadja, Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin. Microbiol Infect. 28(2), 202&#x2013;221 (2022). https://doi.org/10.1016/j.cmi.2021.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.10.005</ArticleId><ArticleId IdType="pubmed">34715347</ArticleId></ArticleIdList></Reference><Reference><Citation>S.A. Clarke, A. Abbara, W.S. Dhillo, Impact of COVID-19 on the Endocrine System: A Mini-review. Endocrinology 163(1), bqab203 (2022). https://doi.org/10.1210/endocr/bqab203</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endocr/bqab203</ArticleId><ArticleId IdType="pubmed">34543404</ArticleId></ArticleIdList></Reference><Reference><Citation>M. Hoffmann, H. Kleine-Weber, S. Schroeder, N. Kr&#xfc;ger, T. Herrler, S. Erichsen et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 181(2), 271&#x2013;280.e8 (2020). https://doi.org/10.1016/j.cell.2020.02.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId><ArticleId IdType="pmc">7102627</ArticleId></ArticleIdList></Reference><Reference><Citation>L. Cantuti-Castelvetri, R. Ojha, L.D. Pedro, M. Djannatian, J. Franz, S. Kuivanen et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 370(6518), 856&#x2013;860 (2020). https://doi.org/10.1126/science.abd2985</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd2985</ArticleId><ArticleId IdType="pubmed">33082293</ArticleId><ArticleId IdType="pmc">7857391</ArticleId></ArticleIdList></Reference><Reference><Citation>B.A. Johnson, X. Xie, A.L. Bailey, B. Kalveram, K.G. Lokugamage, A. Muruato et al. Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis. Nature 591, 293&#x2013;299 (2021). https://doi.org/10.1038/s41586-021-03237-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03237-4</ArticleId><ArticleId IdType="pubmed">33494095</ArticleId><ArticleId IdType="pmc">8175039</ArticleId></ArticleIdList></Reference><Reference><Citation>T.P. Peacock, D.H. Goldhill, J. Zhou, L. Baillon, R. Frise, O.C. Swann et al. The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets. Nat. Microbiol 6, 899&#x2013;909 (2021). https://doi.org/10.1038/s41564-021-00908-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-021-00908-w</ArticleId><ArticleId IdType="pubmed">33907312</ArticleId></ArticleIdList></Reference><Reference><Citation>D. Wrapp, N. Wang, K.S. Corbett, J.A. Goldsmith, C.L. Hsieh, O. Abiona et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367(6483), 1260&#x2013;1263 (2020). https://doi.org/10.1126/science.abb2507</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2507</ArticleId><ArticleId IdType="pubmed">32075877</ArticleId><ArticleId IdType="pmc">7164637</ArticleId></ArticleIdList></Reference><Reference><Citation>S.M. Gobeil, K. Janowska, S. McDowell, K. Mansouri, R. Parks, K. Manne et al. D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction. Cell Rep. 34(2), 108630 (2021). https://doi.org/10.1016/j.celrep.2020.108630</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108630</ArticleId><ArticleId IdType="pubmed">33417835</ArticleId></ArticleIdList></Reference><Reference><Citation>A.C. Walls, Y.J. Park, M.A. Tortorici, A. Wall, A.T. McGuire, D. Veesler, Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell 181(2), 281&#x2013;292.e6 (2020). https://doi.org/10.1016/j.cell.2020.02.058</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.058</ArticleId><ArticleId IdType="pubmed">32155444</ArticleId><ArticleId IdType="pmc">7102599</ArticleId></ArticleIdList></Reference><Reference><Citation>R. Yan, Y. Zhang, Y. Li, L. Xia, Y. Guo, Q. Zhou, Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367(6485), 1444&#x2013;1448 (2020). https://doi.org/10.1126/science.abb2762</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2762</ArticleId><ArticleId IdType="pubmed">32132184</ArticleId><ArticleId IdType="pmc">7164635</ArticleId></ArticleIdList></Reference><Reference><Citation>C.B. Jackson, M. Farzan, B. Chen, H. Choe, Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol. 23, 3&#x2013;20 (2022). https://doi.org/10.1038/s41580-021-00418-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>The Human Protein Atlas: https://www.proteinatlas.org . Last accessed on May 17, 2023</Citation></Reference><Reference><Citation>L. He, Y. Ding, Q. Zhang, X. Che, Y. He, H. Shen et al. Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. J. Pathol. 210(3), 288&#x2013;297 (2006). https://doi.org/10.1002/path.2067</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.2067</ArticleId><ArticleId IdType="pubmed">17031779</ArticleId><ArticleId IdType="pmc">7167655</ArticleId></ArticleIdList></Reference><Reference><Citation>S. Elkattawy, R. Alyacoub, S. Ayad, M. Pandya, A. Eckman, A Novel Case of Hypoparathyroidism Secondary to SARS-CoV-2 Infection. Cureus 12(8), e10097 (2020). https://doi.org/10.7759/cureus.10097</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.10097</ArticleId><ArticleId IdType="pubmed">33005518</ArticleId><ArticleId IdType="pmc">7522187</ArticleId></ArticleIdList></Reference><Reference><Citation>S. Bossoni, L. Chiesa, A. Giustina, Severe hypocalcemia in a thyroidectomized woman with Covid-19 infection. Endocrine 68(2), 253&#x2013;254 (2020). https://doi.org/10.1007/s12020-020-02326-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02326-0</ArticleId><ArticleId IdType="pubmed">32346814</ArticleId><ArticleId IdType="pmc">7188455</ArticleId></ArticleIdList></Reference><Reference><Citation>M. Dianatfar, M. Sanjari, B. Dalfardi, Hypoparathyroidism after COVID-19 Pneumonia. Shiraz E-Med J. 22, e115832 (2021)</Citation></Reference><Reference><Citation>J.B. Bonnet, E. Berchoux, A. Sultan, Decompensated primary hypoparathyroidism in a patient with COVID-19. Ann. Endocrinol. 82(2), 123&#x2013;124 (2021). https://doi.org/10.1016/j.ando.2021.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ando.2021.02.002</ArticleId></ArticleIdList></Reference><Reference><Citation>B. Pla, M. Silva, A. Arranz, M. Marazuela, Hipocalcemia severa y resistente al tratamiento en paciente con neumon&#xed;a bilateral COVID-19 [Severe and treatment-resistant hypocalcemia in patient with bilateral COVID-19 pneumonia]. Endocrinol. Diabetes Nutr. 68(7), 518&#x2013;519 (2021). https://doi.org/10.1016/j.endinu.2020.06.002</Citation></Reference><Reference><Citation>V.E. Georgakopoulou, P. Avramopoulos, P. Papalexis, A. Bitsani, C. Damaskos, A. Garmpi et al. COVID-19 induced hypoparathyroidism: A case report. Exp. Ther. Med 23(5), 346 (2022). https://doi.org/10.3892/etm.2022.11276</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2022.11276</ArticleId><ArticleId IdType="pubmed">35401797</ArticleId><ArticleId IdType="pmc">8988155</ArticleId></ArticleIdList></Reference><Reference><Citation>D. Grigoravi&#x10d;ius, L. &#x160;iaulien&#x117;, &#x17d;. Visockien&#x117;, Unrecognized Primary Hypoparathyroidism with Severe Hypocalcemia in the Presence of COVID-19 Infection. Acta Med Litu. 29(1), 136&#x2013;143 (2022). https://doi.org/10.15388/Amed.2021.29.1.9</Citation><ArticleIdList><ArticleId IdType="doi">10.15388/Amed.2021.29.1.9</ArticleId><ArticleId IdType="pubmed">36061936</ArticleId><ArticleId IdType="pmc">9428647</ArticleId></ArticleIdList></Reference><Reference><Citation>L. Di Filippo, A.M. Formenti, P. Rovere-Querini, M. Carlucci, C. Conte, F. Ciceri et al. Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19. Endocrine 68(3), 475&#x2013;478 (2020). https://doi.org/10.1007/s12020-020-02383-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02383-5</ArticleId><ArticleId IdType="pubmed">32533508</ArticleId><ArticleId IdType="pmc">7292572</ArticleId></ArticleIdList></Reference><Reference><Citation>L. Di Filippo, A.M. Formenti, M. Doga, S. Frara, P. Rovere-Querini, E. Bosi, Hypocalcemia is a distinctive biochemical feature of hospitalized COVID-19 patients. Endocrine 71(1), 9&#x2013;13 (2021)</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02541-9</ArticleId><ArticleId IdType="pubmed">33165763</ArticleId></ArticleIdList></Reference><Reference><Citation>L. Di Filippo, A.M. Formenti, M. Doga, E. Pedone, P. Rovere-Querini, A. Giustina, Radiological Thoracic Vertebral Fractures are Highly Prevalent in COVID-19 and Predict Disease Outcomes. J. Clin. Endocrinol. Metab. 106(2), e602&#x2013;e614 (2021). https://doi.org/10.1210/clinem/dgaa738</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgaa738</ArticleId><ArticleId IdType="pubmed">33159451</ArticleId></ArticleIdList></Reference><Reference><Citation>A. Raesi, E. Saedi Dezaki, H. Moosapour, F. Saeidifard, Z. Habibi, F. Rahmani et al. Hypocalcemia in Covid-19: A Prognostic Marker for Severe Disease. Iran. J. Pathol. 16(2), 144&#x2013;153 (2021). https://doi.org/10.30699/IJP.2020.130491.2442</Citation><ArticleIdList><ArticleId IdType="doi">10.30699/IJP.2020.130491.2442</ArticleId><ArticleId IdType="pubmed">33936225</ArticleId></ArticleIdList></Reference><Reference><Citation>E. Puca, E. Puca, P. Pipero, H. Kraja, N. Como, Severe hypocalcaemia in a COVID-19 female patient. Endocrinol. Diabetes Metab. Case Rep. 2021, 20&#x2013;0097 (2021). https://doi.org/10.1530/EDM-20-0097</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EDM-20-0097</ArticleId><ArticleId IdType="pubmed">33522493</ArticleId><ArticleId IdType="pmc">7849476</ArticleId></ArticleIdList></Reference><Reference><Citation>A. Abobaker, A. Alzwi, The effect of COVID-19 on parathyroid glands. J. Infect. Public Health 14(6), 724&#x2013;725 (2021). https://doi.org/10.1016/j.jiph.2021.04.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2021.04.002</ArticleId><ArticleId IdType="pubmed">34020212</ArticleId><ArticleId IdType="pmc">8040319</ArticleId></ArticleIdList></Reference><Reference><Citation>Y. Ding, L. He, Q. Zhang, Z. Huang, X. Che, J. Hou et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J. Pathol. 203(2), 622&#x2013;630 (2004). https://doi.org/10.1002/path.1560</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1560</ArticleId><ArticleId IdType="pubmed">15141376</ArticleId><ArticleId IdType="pmc">7167761</ArticleId></ArticleIdList></Reference><Reference><Citation>A.K. Murugan, A.S. Alzahrani, SARS-CoV-2: Emerging Role in the Pathogenesis of Various Thyroid Diseases. J. Inflamm. Res 14, 6191&#x2013;6221 (2021). https://doi.org/10.2147/JIR.S332705</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S332705</ArticleId><ArticleId IdType="pubmed">34853527</ArticleId><ArticleId IdType="pmc">8628126</ArticleId></ArticleIdList></Reference><Reference><Citation>R. Krapf, P. Jaeger, H.N. Hulter, Chronic respiratory alkalosis induces renal PTH-resistance, hyperphosphatemia and hypocalcemia in humans. Kidney Int 42(3), 727&#x2013;734 (1992). https://doi.org/10.1038/ki.1992.340</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.1992.340</ArticleId><ArticleId IdType="pubmed">1405350</ArticleId></ArticleIdList></Reference><Reference><Citation>G. Alfano, F. Fontana, G. Mori, F. Giaroni, A. Ferrari, S. Giovanella et al. Modena Covid-19 Working Group (MoCo19). Acid base disorders in patients with COVID-19. Int Urol. Nephrol. 54(2), 405&#x2013;410 (2022). https://doi.org/10.1007/s11255-021-02855-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11255-021-02855-1</ArticleId><ArticleId IdType="pubmed">34115260</ArticleId></ArticleIdList></Reference><Reference><Citation>A.K. Murugan, A.S. Alzahrani, SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves&#x2019; disease. Endocrine 73(2), 243&#x2013;254 (2021). https://doi.org/10.1007/s12020-021-02770-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-021-02770-6</ArticleId><ArticleId IdType="pubmed">34106438</ArticleId><ArticleId IdType="pmc">8188762</ArticleId></ArticleIdList></Reference><Reference><Citation>S. Fabbri, R. Zonefrati, G. Galli, G. Gronchi, G. Perigli, A. Borrelli, M.L. Brandi, In Vitro Control of Genes Critical for Parathyroid Embryogenesis by Extracellular Calcium. J. Endocr. Soc. 4(7), bvaa058 (2020). https://doi.org/10.1210/jendso/bvaa058</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jendso/bvaa058</ArticleId><ArticleId IdType="pubmed">32666007</ArticleId><ArticleId IdType="pmc">7326476</ArticleId></ArticleIdList></Reference><Reference><Citation>B.L. Jones, S.M. Smith, Calcium-Sensing Receptor: A Key Target for Extracellular Calcium Signaling in Neurons. Front Physiol. 7, 116 (2016). https://doi.org/10.3389/fphys.2016.00116</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2016.00116</ArticleId><ArticleId IdType="pubmed">27065884</ArticleId><ArticleId IdType="pmc">4811949</ArticleId></ArticleIdList></Reference><Reference><Citation>V.N. Shah, B. Chagot, W.J. Chazin, Calcium-Dependent Regulation of Ion Channels. Calcium Bind Proteins 1(4), 203&#x2013;212 (2006)</Citation><ArticleIdList><ArticleId IdType="pubmed">28757812</ArticleId><ArticleId IdType="pmc">5531595</ArticleId></ArticleIdList></Reference><Reference><Citation>H.A. Lysbeth, W.H. Quenton, M.I. Callum, R. Kiefer, O. Nikitas, S. Eoin, et al.: The SARS-CoV-2 envelope (E) protein forms a calcium- and voltage-activated calcium channel. https://doi.org/10.1101/2022.10.11.511775.</Citation></Reference><Reference><Citation>R. Minakshi, K. Padhan, S. Rehman, M.I. Hassan, F. Ahmad, The SARS coronavirus 3a protein binds calcium in its cytoplasmic domain. Virus Res. 191, 180&#x2013;183 (2014). https://doi.org/10.1016/j.virusres.2014.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2014.08.001</ArticleId><ArticleId IdType="pubmed">25116391</ArticleId></ArticleIdList></Reference><Reference><Citation>M.-S. Jo&#xe3;o, H.S. Noah, K.W. Harrison, J.M. Matthew, S.M. Venkata, J.D. Aurelio et al. pH- and Calcium-Dependent Aromatic Network in the SARS-CoV-2 Envelope Protein. J. Am. Chem. Soc. 144(15), 6839&#x2013;6850 (2022). https://doi.org/10.1021/jacs.2c00973</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.2c00973</ArticleId></ArticleIdList></Reference><Reference><Citation>G. Khelashvili, A. Plante, M. Doktorova, H. Weinstein, Ca2+-dependent mechanism of membrane insertion and destabilization by the SARS-CoV-2 fusion peptide. Biophys. J. 120(6), 1105&#x2013;1119 (2021). https://doi.org/10.1016/j.bpj.2021.02.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2021.02.023</ArticleId><ArticleId IdType="pubmed">33631204</ArticleId><ArticleId IdType="pmc">7899928</ArticleId></ArticleIdList></Reference><Reference><Citation>P. Singh, S. Mukherji, S. Basak, M. Hoffmann, D.K. Das, Dynamic Ca2+ sensitivity stimulates the evolved SARS-CoV-2 spike strain-mediated membrane fusion for enhanced entry. Cell Rep. 39(3), 110694 (2022). https://doi.org/10.1016/j.celrep.2022.110694</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2022.110694</ArticleId><ArticleId IdType="pubmed">35397208</ArticleId><ArticleId IdType="pmc">8993541</ArticleId></ArticleIdList></Reference><Reference><Citation>Y. Zhou, T.K. Frey, J.J. Yang, Viral calciomics: interplays between Ca2+ and virus. Cell Calcium 46(1), 1&#x2013;17 (2009). https://doi.org/10.1016/j.ceca.2009.05.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2009.05.005</ArticleId><ArticleId IdType="pubmed">19535138</ArticleId><ArticleId IdType="pmc">3449087</ArticleId></ArticleIdList></Reference><Reference><Citation>Z.M. Liu, J.P. Li, S.P. Wang, D.Y. Chen, W. Zeng, S.C. Chen et al. Association of procalcitonin levels with the progression and prognosis of hospitalized patients with COVID-19. Int J. Med Sci. 17(16), 2468&#x2013;2476 (2020). https://doi.org/10.7150/ijms.48396</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.48396</ArticleId><ArticleId IdType="pubmed">33029089</ArticleId><ArticleId IdType="pmc">7532477</ArticleId></ArticleIdList></Reference><Reference><Citation>L. Iamartino, M.L. Brandi, The calcium-sensing receptor in inflammation: Recent updates. Front Physiol. 13, 1059369 (2022). https://doi.org/10.3389/fphys.2022.1059369</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2022.1059369</ArticleId><ArticleId IdType="pubmed">36467702</ArticleId><ArticleId IdType="pmc">9716066</ArticleId></ArticleIdList></Reference><Reference><Citation>B. Torres, P. Alcubilla, A. Gonz&#xe1;lez-Cord&#xf3;n, A. Inciarte, M. Chumbita, C. Cardozo et al. COVID19 Hospital Cl&#xed;nic Infectious Diseases Research Group. Impact of low serum calcium at hospital admission on SARS-CoV-2 infection outcome. Int J. Infect. Dis. 104, 164&#x2013;168 (2021). https://doi.org/10.1016/j.ijid.2020.11.207</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.11.207</ArticleId><ArticleId IdType="pubmed">33278624</ArticleId></ArticleIdList></Reference><Reference><Citation>S. Bennouar, A.B. Cherif, A. Kessira, D.E. Bennouar, S. Abdi, Vitamin D Deficiency and Low Serum Calcium as Predictors of Poor Prognosis in Patients with Severe COVID-19. J. Am. Coll. Nutr. 40(2), 104&#x2013;110 (2021). https://doi.org/10.1080/07315724.2020.1856013</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07315724.2020.1856013</ArticleId><ArticleId IdType="pubmed">33434117</ArticleId></ArticleIdList></Reference><Reference><Citation>C. Yang, X. Ma, J. Wu, J. Han, Z. Zheng, H. Duan et al. Low serum calcium and phosphorus and their clinical performance in detecting COVID-19 patients. J. Med Virol. 93(3), 1639&#x2013;1651 (2021). https://doi.org/10.1002/jmv.26515</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26515</ArticleId><ArticleId IdType="pubmed">32926424</ArticleId></ArticleIdList></Reference><Reference><Citation>S. Hashemipour, S. Kiani, P. Shahsavari, S. Afshar, A. Ghobadi, S.M.R.H. Khairkhahan et al. Hypocalcemia in hospitalized patients with COVID-19: roles of hypovitaminosis D and functional hypoparathyroidism. J. Bone Min. Metab. 40(4), 663&#x2013;669 (2022). https://doi.org/10.1007/s00774-022-01330-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00774-022-01330-w</ArticleId></ArticleIdList></Reference><Reference><Citation>J. Liu, P. Han, J. Wu, J. Gong, D. Tian, Prevalence and predictive value of hypocalcemia in severe COVID-19 patients. J. Infect. Public Health 13(9), 1224&#x2013;1228 (2020). https://doi.org/10.1016/j.jiph.2020.05.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2020.05.029</ArticleId><ArticleId IdType="pubmed">32622796</ArticleId><ArticleId IdType="pmc">7306733</ArticleId></ArticleIdList></Reference><Reference><Citation>J.K. Sun, W.H. Zhang, L. Zou, Y. Liu, J.J. Li, X.H. Kan et al. Serum calcium as a biomarker of clinical severity and prognosis in patients with coronavirus disease 2019. Aging 12(12), 11287&#x2013;11295 (2020). https://doi.org/10.18632/aging.103526</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103526</ArticleId><ArticleId IdType="pubmed">32589164</ArticleId><ArticleId IdType="pmc">7343468</ArticleId></ArticleIdList></Reference><Reference><Citation>A. Pizzini, M. Aichner, S. Sahanic, A. B&#xf6;hm, A. Egger, G. Hoermann et al. Impact of Vitamin D Deficiency on COVID-19-A Prospective Analysis from the CovILD Registry. Nutrients 12(9), 2775 (2020). https://doi.org/10.3390/nu12092775</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12092775</ArticleId><ArticleId IdType="pubmed">32932831</ArticleId><ArticleId IdType="pmc">7551662</ArticleId></ArticleIdList></Reference><Reference><Citation>J.P. Bilezikian, A.A. Khan, J.T. Potts Jr., Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J. Clin. Endocrinol. Metab. 94(2), 335&#x2013;339 (2009). https://doi.org/10.1210/jc.2008-1763</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2008-1763</ArticleId><ArticleId IdType="pubmed">19193908</ArticleId><ArticleId IdType="pmc">3214274</ArticleId></ArticleIdList></Reference><Reference><Citation>J.P. Bilezikian, A. Khan, J.T. Potts Jr, M.L. Brandi, B.L. Clarke, D. Shoback et al. Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J. Bone Min. Res 26(10), 2317&#x2013;2337 (2011). https://doi.org/10.1002/jbmr.483</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.483</ArticleId></ArticleIdList></Reference><Reference><Citation>B.L. Clarke, E.M. Brown, M.T. Collins, H. J&#xfc;ppner, P. Lakatos, M.A. Levine et al. Epidemiology and Diagnosis of Hypoparathyroidism. J. Clin. Endocrinol. Metab. 101(6), 2284&#x2013;2299 (2016). https://doi.org/10.1210/jc.2015-3908</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2015-3908</ArticleId><ArticleId IdType="pubmed">26943720</ArticleId><ArticleId IdType="pmc">5393595</ArticleId></ArticleIdList></Reference><Reference><Citation>N. Siraj, Y. Hakami, A. Khan, Medical Hypoparathyroidism. Endocrinol. Metab. Clin. North Am. 47(4), 797&#x2013;808 (2018). https://doi.org/10.1016/j.ecl.2018.07.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ecl.2018.07.006</ArticleId><ArticleId IdType="pubmed">30390814</ArticleId></ArticleIdList></Reference><Reference><Citation>J.P. Bilezikian, Hypoparathyroidism. J. Clin. Endocrinol. Metab. 105(6), 1722&#x2013;1736 (2020). https://doi.org/10.1210/clinem/dgaa113</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgaa113</ArticleId><ArticleId IdType="pubmed">32322899</ArticleId><ArticleId IdType="pmc">7176479</ArticleId></ArticleIdList></Reference><Reference><Citation>D. Shoback, Clinical practice. Hypoparathyroidism. N. Engl. J. Med 359(4), 391&#x2013;403 (2008). https://doi.org/10.1056/NEJMcp0803050</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcp0803050</ArticleId><ArticleId IdType="pubmed">18650515</ArticleId></ArticleIdList></Reference><Reference><Citation>C.J. Goddard, A. Mbewu, J.M. Evanson, Symptomatic hypocalcaemia associated with metastatic invasion of the parathyroid glands. Br. J. Hosp. Med 43(1), 72 (1990)</Citation><ArticleIdList><ArticleId IdType="pubmed">2302485</ArticleId></ArticleIdList></Reference><Reference><Citation>G. Mazziotti, E. Lavezzi, A. Brunetti, M. Mirani, G. Favacchio, A. Pizzocaro et al. Humanitas COVID19 Task Force. Vitamin D deficiency, secondary hyperparathyroidism and respiratory insufficiency in hospitalized patients with COVID-19. J. Endocrinol. Investig. 44(10), 2285&#x2013;2293 (2021). https://doi.org/10.1007/s40618-021-01535-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-021-01535-2</ArticleId></ArticleIdList></Reference><Reference><Citation>L. di Filippo, A. Allora, M. Locatelli, P. Rovere Querini, S. Frara, G. Banfi et al. Hypocalcemia in COVID-19 is associated with low vitamin D levels and impaired compensatory PTH response. Endocrine 74(2), 219&#x2013;225 (2021). https://doi.org/10.1007/s12020-021-02882-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-021-02882-z</ArticleId><ArticleId IdType="pubmed">34586582</ArticleId><ArticleId IdType="pmc">8480127</ArticleId></ArticleIdList></Reference><Reference><Citation>M.F. Siddiqui, N. Maalouf, Spontaneous Resolution of Primary Hyperparathyroidism Following COVID-19 Infection. J. Endocr. Soc. 5(Suppl_1), A223&#x2013;A224 (2021). https://doi.org/10.1210/jendso/bvab048.454</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jendso/bvab048.454</ArticleId></ArticleIdList></Reference><Reference><Citation>T. Li, L. Wang, H. Wang, Y. Gao, X. Hu, X. Li et al. Characteristics of laboratory indexes in COVID-19 patients with non-severe symptoms in Hefei City, China: diagnostic value in organ injuries. Eur. J. Clin. Microbiol Infect. Dis. 39(12), 2447&#x2013;2455 (2020). https://doi.org/10.1007/s10096-020-03967-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-03967-9</ArticleId><ArticleId IdType="pubmed">32613308</ArticleId><ArticleId IdType="pmc">7329266</ArticleId></ArticleIdList></Reference><Reference><Citation>S. Battisti, N. Napoli, C. Pedone, M. Lombardi, G. Leanza, F. Tramontana et al. Vertebral fractures and mortality risk in hospitalised patients during the COVID-19 pandemic emergency. Endocrine 74(3), 461&#x2013;469 (2021). https://doi.org/10.1007/s12020-021-02872-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-021-02872-1</ArticleId><ArticleId IdType="pubmed">34529239</ArticleId><ArticleId IdType="pmc">8444515</ArticleId></ArticleIdList></Reference><Reference><Citation>M. Tahtabasi, N. Kilicaslan, Y. Akin, E. Karaman, M. Gezer, Y.K. Icen et al. The Prognostic Value of Vertebral Bone Density on Chest CT in Hospitalized COVID-19 Patients. J. Clin. Densitom. 24(4), 506&#x2013;515 (2021). https://doi.org/10.1016/j.jocd.2021.07.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocd.2021.07.007</ArticleId><ArticleId IdType="pubmed">34353732</ArticleId><ArticleId IdType="pmc">8302819</ArticleId></ArticleIdList></Reference><Reference><Citation>A. Giustina, R. Bouillon, N. Binkley, C. Sempos, R.A. Adler, J. Bollerslev et al. Controversies in Vitamin D: A Statement From the Third International Conference. JBMR 4(12), e10417 (2020). https://doi.org/10.1002/jbm4.10417</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbm4.10417</ArticleId></ArticleIdList></Reference><Reference><Citation>J.H. Krege, D. Kendler, K. Krohn, H. Genant, J. Alam, P.Y. Berclaz et al. Relationship Between Vertebral Fracture Burden, Height Loss, and Pulmonary Function in Postmenopausal Women With Osteoporosis. J. Clin. Densitom. 18(4), 506&#x2013;511 (2015). https://doi.org/10.1016/j.jocd.2015.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocd.2015.02.004</ArticleId><ArticleId IdType="pubmed">25824332</ArticleId></ArticleIdList></Reference><Reference><Citation>L. di Filippo, N. Compagnone, S. Frara, A. Allora, M. Doga, P. Rovere Querini et al. Vertebral fractures at hospitalization predict impaired respiratory function during follow-up of COVID-19 survivors. Endocrine 77(2), 392&#x2013;400 (2022). https://doi.org/10.1007/s12020-022-03096-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-022-03096-7</ArticleId><ArticleId IdType="pubmed">35676466</ArticleId></ArticleIdList></Reference><Reference><Citation>L. di Filippo, S. Frara, M. Doga, A. Giustina, The osteo-metabolic phenotype of COVID-19: an update. Endocrine 78(2), 247&#x2013;254 (2022). https://doi.org/10.1007/s12020-022-03135-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-022-03135-3</ArticleId><ArticleId IdType="pubmed">35857271</ArticleId><ArticleId IdType="pmc">9297261</ArticleId></ArticleIdList></Reference><Reference><Citation>N. Napoli, A.L. Elderkin, D.P. Kiel, S. Khosla, Managing fragility fractures during the COVID-19 pandemic. Nat. Rev. Endocrinol. 16(9), 467&#x2013;468 (2020). https://doi.org/10.1038/s41574-020-0379-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-020-0379-z</ArticleId><ArticleId IdType="pubmed">32528045</ArticleId><ArticleId IdType="pmc">7288256</ArticleId></ArticleIdList></Reference><Reference><Citation>H.E. Davis, L. McCorkell, J.M. Vogel, E.J. Topol, Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol 21(3), 133&#x2013;146 (2023). https://doi.org/10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId><ArticleId IdType="pmc">9839201</ArticleId></ArticleIdList></Reference><Reference><Citation>N. Aojula, A. Ready, N. Gittoes, Z. Hassan-Smith, Management of Parathyroid Disease during the COVID-19 Pandemic. J. Clin. Med. 10(5), 920 (2021). https://doi.org/10.3390/jcm10050920</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10050920</ArticleId><ArticleId IdType="pubmed">33652905</ArticleId><ArticleId IdType="pmc">7956309</ArticleId></ArticleIdList></Reference><Reference><Citation>E.M. Alfadhli, Management of Primary Hyperparathyroidism With Severe Hypercalcemia During the COVID-19 Pandemic. Clin. Ther. 43(4), 711&#x2013;719 (2021). https://doi.org/10.1016/j.clinthera.2021.02.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2021.02.003</ArticleId><ArticleId IdType="pubmed">33752899</ArticleId><ArticleId IdType="pmc">7976275</ArticleId></ArticleIdList></Reference><Reference><Citation>F.L.M. Montenegro, M.D.G. Brescia, S.S. Arap, M.A.V. Kulcsar, M.R. Tavares, L.P. Kowalski, Parathyroid surgery during the COVID-19 pandemic: Time to think about the &#x201c;New Normal&#x201d;. Clinics 75, e2218 (2020). https://doi.org/10.6061/clinics/2020/e2218</Citation><ArticleIdList><ArticleId IdType="doi">10.6061/clinics/2020/e2218</ArticleId><ArticleId IdType="pubmed">32844959</ArticleId><ArticleId IdType="pmc">7426598</ArticleId></ArticleIdList></Reference><Reference><Citation>S. Nachimuthu, M.D. Assar, J.M. Schussler, Drug-induced QT interval prolongation: mechanisms and clinical management. Ther. Adv. Drug Saf. 3(5), 241&#x2013;253 (2012). https://doi.org/10.1177/2042098612454283</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2042098612454283</ArticleId><ArticleId IdType="pubmed">25083239</ArticleId><ArticleId IdType="pmc">4110870</ArticleId></ArticleIdList></Reference><Reference><Citation>A.M. Uwitonze, M.S. Razzaque, Role of magnesium in vitamin D activation and function. J. Am. Osteopath Assoc. 118(3), 181&#x2013;189 (2018). https://doi.org/10.7556/jaoa.2018.037</Citation><ArticleIdList><ArticleId IdType="doi">10.7556/jaoa.2018.037</ArticleId><ArticleId IdType="pubmed">29480918</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>